(function(){ var content_array=["
關于<\/b>GSK<\/b>:<\/b><\/p> \n
GSK是一家以科學為導向的全球醫療保健公司,旨在幫助人們能夠做到更多、感覺更舒適、生活更長久。如需更多信息,請訪問www.gsk.com<\/a>。<\/p> \n 【參考資料】 * Monitoring GFR by cystatin-C is a measure of renal function采用胱抑素-C監測GFR是測量腎功能的一種方法。<\/p>"];
$("#dvExtra").html(content_array[0]);})();
<\/b>1 <\/sup>van Wyk J., Ajana F., Bisshop F., et al. Switching to DTG\/3TC fixed-dose combination (FDC) is non-inferior to continuing a TAF-based regimen (TBR) in maintaining virologic suppression through 96 Weeks (TANGO Study). Presented at HIV Glasgow 2020.<\/p> \n